Callander NS, Baljevic M, Adekola K, Anderson LD, Campagnaro E, Castillo JJ, et al. NCCN guidelines® insights: multiple myeloma, version 3.2022. J Natl Compr Canc Netw. 2022;20:8–19.

Article  PubMed  Google Scholar 

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.

Article  PubMed  Google Scholar 

Brigle K, Rogers B. Pathobiology and diagnosis of multiple myeloma. Semin Oncol Nurs. 2017;33:225–36.

Article  PubMed  Google Scholar 

Rajkumar SV, Landgren O, Mateos M-V. Smoldering multiple myeloma. Blood. 2015;125:3069–75.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rajkumar SV. Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol. 2024;99:1802–24.

Article  PubMed  Google Scholar 

Martino EA, Bruzzese A, Iaccino E, Mendicino F, Mimmi S, Lucia E, et al. Isatuximab in multiple myeloma. Expert Opin Biol Ther. 2023;23:315–8.

Article  PubMed  Google Scholar 

Bruzzese A, Martino EA, Vigna E, Iaccino E, Mendicino F, Lucia E, et al. Elotuzumab in multiple myeloma. Expert Opin Biol Ther. 2023;23:7–10.

Article  PubMed  CAS  Google Scholar 

Martino EA, Bruzzese A, Iaccino E, Labanca C, Mendicino F, Mimmi S, et al. Belantamab mafodotin in multiple myeloma. Expert Opin Biol Ther. 2023;23:1043–7.

Article  PubMed  Google Scholar 

van de Donk NWCJ, Zweegman S. Monoclonal antibodies in the treatment of multiple myeloma. Hematol Oncol Clin North Am. 2024;38:337–60.

Article  PubMed  Google Scholar 

Martino EA, Bruzzese A, Labanca C, Mendicino F, Lucia E, Olivito V, et al. Teclistamab-cqyv in multiple myeloma. Eur J Haematol. 2024;112:320–7.

Article  PubMed  CAS  Google Scholar 

Shouse G. Bispecific antibodies for the treatment of hematologic malignancies: the magic is T-cell redirection. Blood Rev. 2025;69:101251.

Article  PubMed  CAS  Google Scholar 

Labanca C, Martino EA, Vigna E, Bruzzese A, Mendicino F, Lucia E, et al. Talquetamab in multiple myeloma: efficacy, safety, and future directions. Eur J Haematol. 2025;114:386–99.

Article  PubMed  CAS  Google Scholar 

Swan D, Madduri D, Hocking J. CAR-T cell therapy in multiple myeloma: current status and future challenges. Blood Cancer J. 2024;14:206.

Article  PubMed  PubMed Central  Google Scholar 

Padala SA, Barsouk A, Barsouk A, Rawla P, Vakiti A, Kolhe R, et al. Epidemiology, staging, and management of multiple myeloma. Medical Sciences. 2021;9:3.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jurczyszyn A, Suska A. Multiple myeloma. Encyclopedia of biomedical gerontology, academic press. 2019;461–78.

Waxman AJ, Mink PJ, Devesa SS, Anderson WF, Weiss BM, Kristinsson SY, et al. Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood. 2010;116:5501–6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cowan AJ, Allen C, Barac A, Basaleem H, Bensenor I, Curado MP, et al. Global burden of multiple myeloma. JAMA Oncol. 2018;4:1221.

Article  PubMed  PubMed Central  Google Scholar 

Schinasi LH, Brown EE, Camp NJ, Wang SS, Hofmann JN, Chiu BC, et al. Multiple myeloma and family history of lymphohaematopoietic cancers: results from the International Multiple Myeloma Consortium. Br J Haematol. 2016;175:87–101.

Article  PubMed  PubMed Central  Google Scholar 

Kaur J, Valisekka SS, Hameed M, Bandi PS, Varma S, Onwughalu CJ, et al. Monoclonal gammopathy of undetermined significance: a comprehensive review. Clin Lymphoma Myeloma Leuk. 2023;23:e195-212.

Article  PubMed  CAS  Google Scholar 

Nwabuko OC. Multiple myeloma: risk factors, pathogenesis and relationship with anti-myeloma therapies. J Explor Res Pharmacol. 2023;000:000–000.

Article  Google Scholar 

Sadeghian M, Ayatollahi H, Keramati M, Memar B, Jamedar S, Avval M, et al. The association of Epstein-Barr Virus infection with multiple myeloma. Indian J Pathol Microbiol. 2011;54:720.

Article  PubMed  Google Scholar 

Rettig MB, Ma HJ, Vescio RA, Põld M, Schiller G, Belson D, et al. Kaposi’s sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science. 1979;1997(276):1851–4.

Google Scholar 

Tentolouris A, Ntanasis-Stathopoulos I, Terpos E. Obesity and multiple myeloma: emerging mechanisms and perspectives. Semin Cancer Biol. 2023;92:45–60.

Article  PubMed  CAS  Google Scholar 

Weir CB, Jan A. BMI classification percentile and cut off points. 2023. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.

Ahmad N, Adam SM, Nawi A, Hassan M, Ghazi H. Abdominal obesity indicators: waist circumference or waist-to-hip ratio in Malaysian adults population. Int J Prev Med. 2016;7:82.

Article  PubMed  PubMed Central  Google Scholar 

Tchernof A, Després J-P. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93:359–404.

Article  PubMed  CAS  Google Scholar 

Goodwin PJ, Stambolic V. Impact of the obesity epidemic on cancer. Annu Rev Med. 2015;66:281–96.

Article  PubMed  CAS  Google Scholar 

Friedman GD, Herrinton LJ. Obesity and multiple myeloma. Cancer Causes Control. 1994;5:479–83.

Article  PubMed  CAS  Google Scholar 

Birmann BM, Andreotti G, De Roos AJ, Camp NJ, Chiu BCH, Spinelli JJ, et al. Young adult and usual adult body mass index and multiple myeloma risk: a pooled analysis in the International Multiple Myeloma Consortium (IMMC). Cancer Epidemiol Biomarkers Prev. 2017;26:876–85.

Article  PubMed  PubMed Central  Google Scholar 

Teras LR, Kitahara CM, Birmann BM, Hartge PA, Wang SS, Robien K, et al. Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies. Br J Haematol. 2014;166:667–76.

Article  PubMed  PubMed Central  Google Scholar 

Tie W, Ma T, Yi Z, Liu J, Li Y, Bai J, et al. Obesity as a risk factor for multiple myeloma: insight on the role of adipokines. Pathol Oncol Res. 2023;29:1611338.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Morris EV, Edwards CM. Adipokines, adiposity, and bone marrow adipocytes: dangerous accomplices in multiple myeloma. J Cell Physiol. 2018;233:9159–66.

Article  PubMed  CAS  Google Scholar 

Chang S-H, Luo S, Thomas TS, O’Brian KK, Colditz GA, Carlsson NP, et al. Obesity and the transformation of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based cohort study. J Natl Cancer Inst. 2017;109:djw264.

Article  PubMed  Google Scholar 

Thordardottir M, Lindqvist EK, Lund SH, Costello R, Burton D, Korde N, et al. Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study. Blood Adv. 2017;1:2186–92.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Veld J, O’Donnell EK, Reagan MR, Yee AJ, Torriani M, Rosen CJ, et al. Abdominal adipose tissue in MGUS and multiple myeloma. Skeletal Radiol. 2016;45:1277–83.